These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9159156)

  • 21. Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone.
    Chatzistamou I; Schally AV; Varga JL; Groot K; Busto R; Armatis P; Halmos G
    Anticancer Drugs; 2001 Oct; 12(9):761-8. PubMed ID: 11593058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
    Plonowski A; Schally AV; Varga JL; Rekasi Z; Hebert F; Halmos G; Groot K
    Prostate; 2000 Jul; 44(2):172-80. PubMed ID: 10881027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors.
    Lamharzi N; Schally AV; Koppán M
    Regul Pept; 1998 Oct; 77(1-3):185-92. PubMed ID: 9809814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of growth of human small cell and non-small cell lung carcinomas by antagonists of growth hormone-releasing hormone (GH-RH).
    Pinski J; Schally A; Jungwirth A; Groot K; Halmos G; Armatis P; Zarandi M; Vadillobuenfil M
    Int J Oncol; 1996 Dec; 9(6):1099-105. PubMed ID: 21541617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity.
    Plonowski A; Varga JL; Schally AV; Krupa M; Groot K; Halmos G
    Int J Cancer; 2002 Apr; 98(4):624-9. PubMed ID: 11920625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.
    Kiaris H; Schally AV
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):226-31. PubMed ID: 9874800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of GHRH aggravated acetaminophen-induced acute mice liver injury through GH/IGF-I axis.
    Wang T; Hai J; Chen X; Peng H; Zhang H; Li L; Zhang Q
    Endocr J; 2012; 59(7):579-87. PubMed ID: 22572547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning.
    Telegdy G; Schally AV
    Behav Brain Res; 2012 Aug; 233(2):326-30. PubMed ID: 22640814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice.
    Jungwirth A; Galvan G; Pinski J; Halmos G; Szepeshazi K; Cai RZ; Groot K; Schally AV
    Prostate; 1997 Aug; 32(3):164-72. PubMed ID: 9254895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma.
    Kiaris H; Schally AV; Varga JL
    Cancer Lett; 2000 Dec; 161(2):149-55. PubMed ID: 11090963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells.
    Horváth JE; Zarándi M; Groot K; Schally AV
    Endocrinology; 1995 Sep; 136(9):3849-55. PubMed ID: 7649091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells.
    Siejka A; Ławnicka H; Komorowski J; Schally AV; Stepień T; Krupiński R; Stepień H
    Life Sci; 2003 Apr; 72(22):2473-9. PubMed ID: 12650855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice.
    Telegdy G; Tanaka M; Schally AV
    Behav Brain Res; 2011 Oct; 224(1):155-8. PubMed ID: 21672558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.
    Halmos G; Schally AV; Varga JL; Plonowski A; Rekasi Z; Czompoly T
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10555-60. PubMed ID: 10962030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth.
    Szepeshazi K; Schally AV; Armatis P; Groot K; Hebert F; Feil A; Varga JL; Halmos G
    Endocrinology; 2001 Oct; 142(10):4371-8. PubMed ID: 11564700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.
    Papadia A; Schally AV; Halmos G; Varga JL; Seitz S; Buchholz S; Rick F; Zarandi M; Bellyei S; Treszl A; Szalontay L; Lucci JA
    Horm Metab Res; 2011 Oct; 43(11):816-20. PubMed ID: 22009378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A; Schally AV; Nagy A; Kiaris H; Hebert F; Halmos G
    Cancer Res; 2000 Jun; 60(11):2996-3001. PubMed ID: 10850448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of GH release of rats by new potent antagonists of growth hormone-releasing hormone (GH-RH).
    Kovács M; Schally AV; Zarándi M; Groot K
    Peptides; 1997; 18(3):431-8. PubMed ID: 9145432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
    Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ
    Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.